| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/05/2003 | EP1280547A2 Mast cell regulation |
| 02/05/2003 | EP1280546A1 Method and composition for the treatment of angiogenesis |
| 02/05/2003 | EP1280542A1 Use of a cell extract of at least a plant of the family pontederiaceae as anti-pollution agent |
| 02/05/2003 | EP1280539A2 Nontoxic vernix compositions and method of producing |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1196187A4 Keratinocyte growth factor-2 formulations |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP1104294A4 Compositions and methods of treating abnormal cell proliferation |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0802782B1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 02/05/2003 | CN1395613A 抗微生物组合物 The antimicrobial composition |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395569A Oxazolidinone thioamides with piperazine amide substituents |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395491A Polymer blends as biodegradable matrices for preparing biocomposites |
| 02/05/2003 | CN1395489A Physiologically balanced ionized acidic solution and methodology for use in wound healing |
| 02/05/2003 | CN1395488A Drospirenone for hormone replacement therapy |
| 02/05/2003 | CN1395484A Substances for use in treating psoriasis |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1394627A Compound injection medicine for quickly-curing vitiligo-Qudianye |
| 02/05/2003 | CN1394626A Medicine for curing burn |
| 02/05/2003 | CN1394622A Medicine for curing burn and scald |
| 02/05/2003 | CN1394618A Medicine for curing psoriasis |
| 02/05/2003 | CN1394617A Medicine for curing vitiligo |
| 02/05/2003 | CN1394594A Amino acid derivative base compound and application and method for dissolving material with low solubility |
| 02/05/2003 | CN1100549C Preparation of external-use Chinese medicine for curing chapped skin and chapped eczema |
| 02/05/2003 | CN1100543C 聚维酮碘膜剂 Povidone iodine agent |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/05/2003 | CN1100538C Lotion |
| 02/05/2003 | CN1100532C Desquamation copositions contaiig salicylic acid and zwitterionic compounds |
| 02/05/2003 | CN1100530C Chinese medicinal herb preparation with function of health body-washing, skin-care and beautifying |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6515004 Useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514972 Heteropolycyclic inhibitors of protein kinases |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514960 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 02/04/2003 | US6514738 Given amino acid sequence; microtubular depolymerization activity in presence of ATP; can be used in diagnosis and treatment of cancer, neurological and vesicular transport disorders. |
| 02/04/2003 | US6514506 Melanin-degrading enzyme extract; twice as effective as kojic acid |
| 02/04/2003 | US6514489 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 02/04/2003 | CA2271478C Tissue specific expression of retinoblastoma protein |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 02/01/2003 | CA2395006A1 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008495A1 Pullulan-containing powder, process for producing the same and use thereof |
| 01/30/2003 | WO2003008457A2 Polysaccharidic esters of retinoic acid |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008438A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 01/30/2003 | WO2003008414A1 Chemical compounds |
| 01/30/2003 | WO2003008412A2 Hetero-bicyclic crf antagonists |
| 01/30/2003 | WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008409A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008399A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/30/2003 | WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 01/30/2003 | WO2003008388A1 I-form crystal of n-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}-n'-propylurea and process for producing the same |
| 01/30/2003 | WO2003008384A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003008365A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/30/2003 | WO2003007993A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 01/30/2003 | WO2003007980A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 01/30/2003 | WO2003007972A1 Agent for the external treatment of pain and skin disorders |
| 01/30/2003 | WO2003007960A1 Method for protecting human skin against infections and a dermatic for carrying out said method |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007951A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/30/2003 | WO2003007950A1 (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2003007927A1 Synthesis and functin inhibitors for heat shock proteins |
| 01/30/2003 | WO2003007922A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 01/30/2003 | WO2003007907A1 Water-free ubichinon concentrate |
| 01/30/2003 | WO2003007905A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 01/30/2003 | WO2003007875A2 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 01/30/2003 | WO2003007873A2 Plasma protein matrices and methods for their preparation |
| 01/30/2003 | WO2003007871A2 Process for the preparation of acitretin |
| 01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
| 01/30/2003 | WO2003007686A2 Use of copper chelators to inhibit the inactivation of protein c |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | WO2002064160A8 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 01/30/2003 | WO2002055101A3 Storage stable powder compositions of interleukin-4 receptor |
| 01/30/2003 | WO2002049642A3 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis |
| 01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/30/2003 | WO2002018375A1 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof |
| 01/30/2003 | WO2002018351A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | US20030023283 Method and apparatus for the stimulation of hair growth |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |